Due to the vast implication of androgen receptor antagonists for castration-resistant prostate cancers (CRPC), neuroendocrinal progression of prostate cancer (NEPC) emerged as the worst stage of prostate cancer without means to cure (23, 24). Here, AR is linked to prostate cancer.